Before and after IPO website and digital consultation

Online presence for a UK-based specialty biopharma company

Produced as a key communications tool when the Mereo BioPharma founded in March 2015, thinkerdoer created a new website for the company as they pushed towards completing a private financing round of £76.5 million.

Mereo acquired an initial portfolio of three strong pipeline products from Novartis, each with a comprehensive and robust package of Phase 2 clinically-meaningful data. In June 2016 the company joined the London Stock Exchange’s AIM market and thinkerdoer expanded the site with a comprehensive investor section to comply with best practice guidelines.

websites and online presence / investor communication materials